Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--III. The effects of monoamine antagonists and synthesis inhibitors on the ability of electroconvulsive shock to enhance responses.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D004298:Dopamine / Q000502:physiology*; D004597:Electroshock; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D008995:Monoamine Oxidase / Q000096:biosynthesis; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D012640:Seizures / Q000503:physiopathology*; D012701:Serotonin / Q000502:physiology*
D006892:Hydroxydopamines; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D008995:Monoamine Oxidase; D004298:Dopamine; D009638:Norepinephrine